Table 3b.
Number (%) of COVID-19 cases without PCC diagnosed with the most common diagnoses (main and secondary) more than 28 days after COVID-19 index date, stratified according to the initial care requirement for COVID-19. Study population from the two largest regions in Sweden, Stockholm and Västra Götaland, including both primary healthcare data and inpatient/outpatient specialist healthcare data, until 15 February 2022.
| COVID-19 cases without PCC |
||||
|---|---|---|---|---|
| Acute COVID-19 care level/ Diagnoses after COVID-19a | Non-hospitalized (n = 471,079) | Hospitalized, non-ICU (n = 23,249) | Hospitalized, ICU (n = 1583) | All (n = 495,911) |
| I10.9 Essential hypertension | 53,910 (11.4) | 11,166 (48.0) | 864 (54.6) | 65,940 (13.3) |
| R52.9 Pain, unspecified | 61,056 (13.0) | 4,060 (17.5) | 265 (16.7) | 65,381 (13.2) |
| R53.9 Malaise and fatigue | 36,047 (7.7) | 3,688 (15.9) | 274 (17.3) | 40,009 (8.1) |
| R05.9 Cough, unspecified | 35,254 (7.5) | 4,106 (17.7) | 356 (22.5) | 39,716 (8.0) |
| J06.9 Acute upper respiratory infection, unspecified | 32,453 (6.9) | 1,720 (7.4) | 113 (7.1) | 34,286 (6.9) |
| R10.4X Abdominal pain, unspecified | 29,238 (6.2) | 2,875 (12.4) | 157 (9.9) | 32,270 (6.5) |
| F41.9 Anxiety disorder, unspecified | 23,855 (5.1) | 1,399 (6.0) | 78 (4.9) | 25,332 (5.1) |
| R06.0 Dyspnea | 16,743 (3.6) | 7,578 (32.6) | 758 (47.9) | 25,079 (5.1) |
| G47.9 Sleep disorder, unspecified | 21,337 (4.5) | 2,003 (8.6) | 162 (10.2) | 23,502 (4.7) |
| R51.9 Headache, unspecified | 20,888 (4.4) | 1,341 (5.8) | 75 (4.7) | 22,304 (4.5) |
Diagnoses from the U-chapter excluded.
ICU, intensive care unit; PCC, post-COVID-19 condition.
a
Diagnoses from healthcare visits from day 29 after COVID-19 index date until end of follow-up.